CitiusTech announces leadership transition with Dhaval Shah as Acting CEO and Shyam Karunakaran as President

image credit- freepik

CitiusTech, a leading digital and enterprise AI company for healthcare and life sciences organisations, has announced that Dhaval Shah, Chief Business Officer for the MedTech (HMT) and Life Sciences (HLS) markets, has been elevated to the role of Acting Chief Executive Officer (CEO), effective immediately.

Shyam Karunakaran, Chief Business Officer for Healthcare Payer & Platforms (HHP & Platforms), has been elevated to the role of President, with broad responsibilities spanning enterprise strategy, markets, growth, and execution.

Rajan Kohli, Chief Executive Officer, has decided to move on from his role by the end of August 2026 to pursue other opportunities.

Dhaval Shah has been with the company for more than 19 years, helping shape its culture, values, and operating model since its earliest days. Over his tenure, Shah has held various leadership roles and was responsible in building the company’s MedTech and Life Sciences businesses. Until recently, he served as Chief Business Officer for these industry segments.

Karunakaran has spent 17 years at CitiusTech. He served as Chief Business Officer for the company's Payer and Platform businesses and helped build them into the franchises they are today. As President, he will bring that same strategic mandate to the broader organisation, with responsibilities across enterprise strategy, markets, growth, and execution.